ABVC BioPharma, Inc. (ABVC) Tops Q3 EPS by 38c

ABVC BioPharma, Inc. (NASDAQ: ABVC) reported Q3 EPS of ($0.02), $0.38 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $380 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on ABVC BioPharma, Inc. (ABVC) click here.

You May Also Be Interested In

• Benchmark Electronics (BHE) Tops Q2 EPS by 16c; offers guidance
• Vista Gold Corp (VGZ) Reports Q2 Loss of $0.02
• NPK International Inc. (NPKI) Tops Q2 EPS by 2c